Novel form of (R)-N-(5-methyl-8-(4-methylpiperazin-1YL)-1,2,3,4-tetrahydro - 2-naphthyl)-4-morpholinobenzamide

Details for Australian Patent Application No. 2001272872 (hide)

Owner AstraZeneca AB

Inventors Stahle, Erica; Lindstrom, Mona; Hedberg, Martin; Bergstrom, Per-Olov

Agent Freehills

Pub. Number AU-B-2001272872

PCT Pub. Number WO02/08212

Priority 0002729 20.07.00 SE

Filing date 17 July 2001

Wipo publication date 5 February 2002

Acceptance publication date 25 August 2005

International Classifications

C07D 295/04 Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

C07D 413/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

25 August 2005 Application Accepted

  Published as AU-B-2001272872

22 December 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001272873

2001272871